Correction to: A Translational Quantitative Systems Pharmacology Model for CD3 Bispecific Molecules: Application to Quantify T Cell-Mediated Tumor Cell Killing by P-Cadherin LP DART®
AAPS J. 2019 Jun 4;21(4):73.
doi: 10.1208/s12248-019-0348-4.
1 Department of Biomedicine Design, Pfizer Inc., 610 Main Street, Cambridge, Massachusetts, 02139, USA. alison.betts@pfizer.com.
2 Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, 2300 RA, Leiden, The Netherlands. alison.betts@pfizer.com.
3 Janssen Research & Development, LLC, Spring House, Pennsylvania, 19477, USA.
4 Department of Pharmaceutical Sciences, 455 Kapoor Hall, University at Buffalo, The State University of New York, Buffalo, New York, 14214-8033, USA.
5 Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, 2300 RA, Leiden, The Netherlands.
6 Oncology Research Unit, Pfizer Inc., 401 N Middletown Rd., Pearl River, New York, 10965, USA.
7 Department of Biomedicine Design, Pfizer Inc., 1 Burtt Road, Andover, Massachusetts, USA.
8 Established Med Business, Pfizer Inc., Eastern Point Rd, Groton, Connecticut, 06340, USA.
9 Department of Immunotoxicology, Pfizer Inc., 558 Eastern Point Road, Groton, Connecticut, 06340, USA.
10 Department of Biomedicine Design, Pfizer Inc., 610 Main Street, Cambridge, Massachusetts, 02139, USA.
11 Department of Clinical Pharmacology, Pfizer Inc., 10555 Science Center Dr., San Diego, California, 92121, USA.